Somatic hypotheses of war syndromes

European Journal of Clinical Investigation

Volumn 30, Issue 7, 2000, Pages 630-641

  Soetekouw, P M M B ^a   De Vries, M ^a   Van Bergen, L ^b   Galama, J M D ^a   Keyser, A ^a   Bleijenberg, G ^a   Van Der Meer, J W M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Gulf War Syndrome; Hypotheses; Unexplained symptoms; War syndromes

Indexed keywords

CHEMOPROPHYLAXIS; ENVIRONMENTAL FACTOR; IMMUNOPATHOLOGY; PERSIAN GULF SYNDROME; PERSISTENT INFECTION; PRIORITY JOURNAL; REVIEW; SOLDIER; SYNDROME; WAR;

COMBAT DISORDERS; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; MILITARY MEDICINE; PERSIAN GULF SYNDROME; UNITED STATES;

EID: 0033948302     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2000.00678.x     Document Type: Review

References (107)

1. 1 De Vries M, Soetekouw PMMB, Bleijenberg G, Van der Meer JWM. Post-Cambodja Klachten Onderzoek Fase I: een inventariserend onderzoek naar aard, omvang en onstaanswijze. [Post-Cambodia Compaints Study Phase I: an inventory of nature, extent and origin]. Nijmegen, the Netherlands: St Radboud University Hospital Nijmegen;1998.
2. 2 Binneveld H. Om de geest van Jan Soldaat: beknopte geschiedenis van de militaire psychiatrie. [On the soldier's spirit. A Concise History of Military Psychiatry]. Rotterdam: Erasmus Publishing;1995.
3. 3 Hyams KG, Wignall FS, Roswell R. War syndromes and their evaluation: from the U.S. Civil War to the Persian Gulf War. Ann Intern Med 1996;125:398-405.
4. 4 Skerritt PW. Anxiety and the heart - a historical review. Psychol Med 1983;13:17-25.
5. 5 De Vries M, Soetekouw PMMB, Van Bergen LFJM, Van der Meer JWM, Bleijenberg G. Lichamelijke en psychische klachten bij militairen na oorlogshandelingen en vredesmissies. [Somatic and psychological complaints after acts of war and peace keeping operations.] Ned Tijdschr Geneeskd 1999;143:2557-62.
6. 6 Da Costa JM. On irritable heart: a clinical study of a form of functional cardiac disorder and its consequences. Am J Med Sci 1871;61:17-52.
7. 7 Howell JD. "Soldier's heart": the redefinition of heart disease and specialty formation in early twentieth-century Great Britain. Med Hist Suppl. 1985;5:34-52.
8. 8 Lewis T. Report on neuro-circulatory asthenia and its management. Military Surgeon 1918;42:409-26.
9. 9 Lewis T. The Soldier's Heart and the Effort Syndrome. New York: P.B. Hoeber;1919.
10. 10 Lewis T. The Soldier's Heart and the Effort Syndrome. 2nd Ed. London: Shaw;1940.
11. 11 Paul O. Da Costa's syndrome or neurocirculatory asthenia. Br Heart J 1987;58:306-15.
12. 12 Health status of Vietnam veterans. II. Physical Health. The Centers for Disease Control Vietnam Experience Study. JAMA 1988;259:2708-14.
13. 13 Health status of Vietnam veterans. I. Psychosocial characteristics. The Centers for Disease Control Vietnam Experience Study. JAMA 1988;259:2701-7.
14. 14 Boyle CA, Decoufle P, O'Brien TR. Long-term health consequences of military service in Vietnam. Epidemiol Rev 1989;11:1-27.
15. 15 Decoufle P, Holmgreen P, Boyle CA, Stroup NE. Self-reported health status of Vietnam veterans in relation to perceived exposure to herbicides and combat. Am J Epidemiol 1992;135:312-23.
16. 16 Bogen G. Symptoms in Vietnam veterans exposed to agent Orange. JAMA 1979;242:2391.
17. 17 Holden C. Agent orange furor continues to build. Science 1979;205:770-2.
18. 18 Haley RW, Kurt TL, Horn J. Is there a Gulf War Syndrome? Searching for syndromes by factor analysis of symptoms [published erratum appears in JAMA 1997;278(5):388]. JAMA 1997;277:215-22.
19. 19 Ismail K, Everitt J, Blatchley N, Hull L, Unwin C, David A et al. Is there a Gulf War Syndrome? Lancet 1999;353:179-82.
20. 20 Mulder YM, Reijneveld SA. Gezondheidsonderzoek UNPROFOR. Een onderzoek onder militairen die uitgezonden zijn geweest naar Lukovac, Santici en Busovaca (Bosnië-Herzegovina) in de periode 1994-95 [Health Research UNPROFOR. A study of soldiers send to Lukovac, Santici and Busovaca (Bosnia-Herzegovina) during 1994-95]. Leiden: TNO Preventie en Gezondheid;1999.
21. 21 SilerJF. The Medical Department of the United States Army in the World War. Vol. 9 Communicable and Other Diseases. Washington, DC: U.S. Government Printing Office;1928.
22. 22 Persian Gulf Veterans Coordinating Board. Summary of the issues impacting upon the health of Persian Gulf Veterans (Version 2.2). Washington, DC.: Persian Gulf Veterans Coordinating Board;1994.
23. 23 Fukuda K, Nisenbaum R, Stewart G, Thompson WW, Robin L, Washko RM et al. Chronic multisymptom illness affecting Air Force veterans of the Gulf War. JAMA 1998;280:981-8.
24. 24 De Vries M, Soetekouw PMMB, Van der Meer JWM, Bleijenberg G. Fatigue in Cambodia veterans: a cross-sectional study. Q J Med 2000;93(5):283-9.
25. 25 Vercoulen JHMM, Swanink CMA, Fennis JFM, Galama JMD, Van der Meer JWM, Bleijenberg G. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res 1994;38:383-92.
26. 26 Wegman DH, Woods NF, Bailar JC. Invited commentary: how would we know a Gulf War syndrome if we saw one? Am J Epidemiol 1997;146:704-11.
27. 27 The Persian Gulf experience and health. NIH Technology Assessment Workshop Panel. JAMA 1994;272:391-6.
28. 28 Persian Gulf Veterans Coordinating Board. Unexplained illnesses among Desert Storm veterans. A search for causes, treatment, and cooperation. Arch Intern Med 1995;155:262-8.
29. 29 Magill AJ, Grogl M, Gasser RA Jr, Sun W, Oster CN. Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm. N Engl J Med 1993;328:1383-7.
30. 30 Hyams KC, Hanson K, Wignall FS, Escamilla J, Oldfield EC. The impact of infectious diseases on the health of U.S. troops deployed to the Persian Gulf during operations Desert Shield and Desert Storm. Clin Infect Dis 1995;20:1497-504.
31. 31 Nicolson GL, Rosenberg Nicolson NL. Doxycycline treatment and Desert Storm [letter]. JAMA 1995;273:618-19.
32. 32 Nicolson GL, Bruton DM Jr, Nicolson NL. Chronic fatigue illness and Operation Desert Storm [letter]. J Occup Environ Med 1996;38:14-16.
33. 33 DeFreitas RF, Wanat ER, Norwood AE, Williams S, Cowan D, Gallahan T. Investigation of a suspected outbreak of an unknown disease among veterans of Operation Desert Shield/ Storm, 123rd Army Reserve Command, Port Benjamin Harrison, Indiana, April 1992, Epidemiologic Consultant Service, Division of Preventive Medicine. Washington, DC: Walter Reed Army Institute of Research;1992.
34. 34 Ferrante MA, Dolan MJ. Q fever meningoencephalitis in a soldier returning from the Persian Gulf War. Clin Infect Dis 1993;16:489-96.
35. 35 Rook GAW, Zumla A. Gulf War syndrome: is it due to a systemic shift in cytokine balance towards a Th2 profile? Lancet 1997;349:1831-3.
36. 36 Kiecolt-Glaser JK, Glaser R, Gavenstein S, Malardkey WB, Sheridan J. Chronic stress alters the immune response to influenza viras vaccine in older adults. Proc Natl Acad Sci USA 1995;93:3043-7.
37. 37 Zhang Q, Zhou XD, Denny T, Ottenweller JE, Lange G, LaManca JJ et al. Changes in immune parameters seen in Gulf War veterans but not in civilians with chronic fatigue syndrome. Clin Diagn Lab Immunol 1999;6:6-13.
38. 38 Swanink CMA, Vercoulen JHMM, Galama JMD, Roos MTL, Meyaard L, Van der Ven-Jongekrijg J et al. Lymphocyte subsets, apoptosis, and cytokines in patients with chronic fatigue syndrome. J Infect Dis 1996;173:460-3.
39. 39 Soetekouw PMMB, Preijers FWMB, Van Crevel R, De Vries M, Bleijenberg G, Van der Meer JWM. Persistent symptoms in former UNTAC soldiers are not associated with shifted cytokine balance. Eur J Clin Invest 1999;29:960-3.
40. 40 Chao CC, Peterson PK, Filice GA, Pomeroy C, Sharp BM. Effects of immobilization stress on the pathogenesis of acute murine toxoplasmosis. Brain Behav Immun 1990;4:162-9.
41. 41 Peterson PK, Chao CC, Molitor T, Murtaugh M, Strgar F, Sharp BM. Stress and pathogenesis of infectious disease. Rev Infect Dis 1991;13:710-20.
42. 42 Chao CC, DeLaHunt M, Hu S, Close K, Peterson PK. Immunologically mediated fatigue: a murine model. Clin Immunol Immunopathol 1992;64:161-5.
43. 43 Chao CC, Strgar F, Tsang M, Peterson PK. Effects of swimming exercise on the pathogenesis of acute murine Toxoplasma gondii Me49 infection. Clin Immunol Immunopathol 1992;62:220-6.
44. 44 Sheng WS, Hu S, Lamkin A, Peterson PK, Chao CC. Susceptibility to immunologically mediated fatigue in C57BL/6 versus Balb/c mice. Clin Immunol Immunopathol 1996;81:161-7.
45. 45 Unwin C, Blatchley N, Coker W, Ferry S, Hotopf M, Hull L et al. Health of UK servicemen who served in Persian Gulf War. Lancet 1999;353:169-78.
46. 46 Weinke T, Trautmann M, Held T, Weber G, Eichenlaub D, Fleischer K et al. Neuropsychiatric side effects after the use of mefloquine. Am J Trop Med Hyg 1991;45:86-91.
47. 47 Hennequin C, Bouree P, Bazin N, Bisaro F, Feline A. Severe psychiatric side effects observed during prophylaxis and treatment with mefloquine. Arch Intern Med 1994;154:2360-2.
48. 48 Hoebe C, de Munter J, Thijs C. Adverse effects and compliance with mefloquine or proguanil antimalarial chemoprophylaxis. Eur J Clin Pharmacol 1997;52:269-75.
49. 49 Van Riemsdijk MM, Van der Klauw MM, Van Heest JA, Reedeker FR, Ligthelm RJ, Herings RM et al. Neuropsychiatric effects of antimalarials. EurJ Clin Pharmacol 1997;52:1-6.
50. 50 Lobel HO, Miani M, Eng T, Bernard KW, Hightower AW, Campbell CC. Long-term malaria prophylaxis with weekly mefloquine. Lancet 1993;341:848-51.
51. 51 Wolters BA, Bosje T, Luinstra-Passchier MJ. Niet meer klachten bij mefloquinegebruik dan bij malariaprofylaxe met andere middelen. [Not more symptoms with mefloquine use than with other drugs in malaria prophylaxis]. Ned Tijdschr Geneeskd 1997;141:331-4.
52. 52 Croft AM, Clayton TC, World MJ. Side effects of mefloquine prophylaxis for malaria: an independent randomized controlled trial. Trans R Soc Trop Med Hyg 1997;91:199-203.
53. 53 Davis TM, Dembo LG, Kaye-Eddie SA, Hewitt BJ, Hislop RG, Batty KT. Neurological, cardiovascular and metabolic effects of mefloquine in healthy volunteers: a double-blind, placebo-controlled trial. Br J Clin Pharmacol 1996;42:415-21.
54. 54 Arthur JD, Shanks GD, Echeverria P. Mefloquine prophylaxis. Lancet 1990;335:972.
55. 55 Arthur JD, Echeverria P, Shanks GD, Karwacki J, Bodhidatta L, Brown JE. A comparative study of gastrointestinal infections in United States soldiers receiving doxycycline or mefloquine for malaria prophylaxis. Am J Trop Med Hyg 1990;43:608-13.
56. 56 Barrett PJ, Emmins PD, Clarke PD, Bradley DJ. Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers. BMJ 1996;313:525-8.
57. 57 Rombo L, Angel VH, Friman G, Hellgren U, Mittelholzer ML, Sturchler D. Comparative tolerability and kinetics during long-term intake of Lariam and Fansidar for malaria prophylaxis in nonimmune volunteers. Trop Med Parasitol 1993;44:254-6.
58. 58 Friedman A, Kaufer D, Shemer J, Hendler I, Soreq H, Tur Kaspa I. Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response. Nat Med 1996;2:1382-5.
59. 59 Belova I, Jonsson G. Blood-brain barrier permeability and immobilization stress. Acta Physiol Scand 1982;116:21-9.
60. 60 Dvorska I, Brust P, Hrbas P, Ruhle HJ, Barth T, Ermisch A. On the blood-brain barrier to peptides: effects of immobilization stress on regional blood supply and accumulation of labelled peptides in the rat brain. Endocr Regul 1992;26:77-82.
61. 61 Ben Nathan D, Lustig S, Danenberg HD. Stress-induced neuroinvasiveness of a neurovirulent noninvasive Sindbis virus in cold or isolation subjected mice. Life Sci 1991;48:1493-500.
62. 62 Sharma HS, Cervos Navarro J, Dey PK. Increased blood-brain barrier permeability following acute short-term swimming exercise in conscious normotensive young rats. Neurosci Res 1991;10:211-21.
63. 63 Pennisi E. Chemicals behind Gulf War syndrome? Science 1996;272:479-80.
64. 64 Kaufer D, Friedman A, Seidman S, Soreq H. Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature 1998;393:373-7.
65. 65 Sapolsky RM. The stress of Gulf War syndrome. Nature 1998;393:308-9.
66. 66 Hanin I. The Gulf War, stress and a leaky blood-brain barrier. Nat Med 1996;2:1307-8.
67. 67 Sharabi Y, Danon YL, Berkenstadt H, Almog S, Mimouni Bloch A, Zisman A et al. Survey of symptoms following intake of pyridostigmine during the Persian Gulf war. Isr J Med Sci 1991;27:656-8.
68. 68 Jamal GA, Hansen S, Apartopoulos F, Peden A. The 'Gulf War syndrome'. Is there evidence of dysfunction in the nervous system? J Neurol Neurosurg Psychiatr 1996;60:449-51.
69. 69 Dyer O. Gulf war veterans show nerve damage. BMJ 1996;312:797.
70. 70 Haley RW, Kurt TL. Self-reported exposure to neurotoxic chemical combinations in the Gulf War. A cross-sectional epidemiologic study. JAMA 1997;277:231-7.
71. 71 Abou-Donia MB, Wilmarth KR, Jensen KF, Oehme FW, Kurt TL. Neurotoxicity resulting from coexposure to pyridostigmine bromide, deet, and permethrin: implications of Gulf War chemical exposures. J Toxicol Environ Health 1996;48:35-56.
72. 72 Multiple chemical sensitivity. A 1999 consensus. Arch Environ Health 1999;54:147-9.
73. 73 Kipen HM, Hallman W, Kelly McNeil K, Fiedler N. Measuring chemical sensitivity prevalence: a questionnaire for population studies. Am J Public Health 1995;85:574-7.
74. 74 Bell IR, Warg Damiani L, Baldwin CM, Walsh ME, Schwanz GE. Self-reported chemical sensitivity and wartime chemical exposures in Gulf War veterans with and without decreased global health ratings. Mil Med 1998;163:725-32.
75. 75 Meggs WJ. Gulf War Syndrome, Chronic Fatigue Syndrome, and the Multiple Chemical Sensitivity Syndrome: stirring the cauldron of confusion. Arch Environ Health 1999;54:309-11.
76. 76 Kipen HM, Hallman W, Kang H, Fiedler N, Natelson BH. Prevalence of chronic fatigue and chemical sensitivities in Gulf Registry Veterans. Arch Environ Health 1999;54:313-8.
77. 77 Urnovitz HB, Tuite JJ, Higashida JM, Murphy WH. RNAs in the sera of Persian Gulf War veterans have segments homologous to chromosome 22q11.2. Clin Diagn Lab Immunol 1999;6:330-5.
78. 78 Penman AD, Currier MM, Tarver RS. No evidence of increase in birth defects and health problems among children born to Persian Gulf War veterans in Mississippi. Mil Med 1996;161:1-6.
79. 79 Cowan DN, DeFraites RF, Gray GC, Goldenbaum MB, Wishik SM. The risk of birth defects among children of Persian Gulf War veterans. N Engl J Med 1997;336:1650-6.
80. 80 Araneta MR, Moore CA, Olney RS, Edmonds LD, Karcher JA, McDonough C et al. Goldenhar syndrome among infants born in military hospitals to Gulf War veterans. Teratology 1997;56:244-51.
81. 81 Revell T. The Gulf War syndrome [letter]. BMJ 1995;310:1073.
82. 82 Sharpe MC, Archard LC, Banatvala JE, Borysiewicz LK, Clare AW, David A et al. A report - chronic fatigue syndrome: guidelines for research. J R Soc Med 1991;84:118-21.
83. 83 Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 1994;121:953-9.
84. 84 Swanink CMA, Vercoulen JHMM, Bleijenberg G, Fennis JFM, Galama JMD, Van der Meer JWM. Chronic fatigue syndrome: a clinical and laboratory study with a well matched control group. J Intern Med 1995;237:499-506.
85. 85 Murphy F, Browne D, Mather S, Scheele H, Hyams KC. Women in the Persian Gulf War: health care implications for active duty troops and veterans. Mil Med 1997;162:656-60.
86. 86 Lyon DS. Medical care of women deployed during Desert Storm. South Med J 1996;89:172-6.
87. 87 Writer JV, DeFraites RF, Brundage JF. Comparative mortality among US military personnel in the Persian Gulf region and worldwide during Operations Desert Shield and Desert Storm. JAMA 1996;275:118-21.
88. 88 Gray GC, Hawksworth AW, Smith TC, Kang HK, Knoke JD, Gackstetter GD. Gulf War Veterans' Health Registries. Who is most likely to seek evaluation? Am J Epidemiol 1998;148:343-9.
89. 89 Roht LH, Vernon SW, Weir FW, Pier SM, Sullivan P, Reed LJ. Community exposure to hazardous waste disposal sites: assessing reporting bias. Am J Epidemiol 1985;122:418-33.
90. 90 Baker DB, Greenland S, Mendlein J, Harmon P. A health study of two communities near the Stringfellow Waste Disposal site. Arch Environ Health 1988;43:325-34.
91. 91 Straus SE. Bridging the gulf in war syndromes. Lancet 1999;353:162-3.
92. 92 Swanink CMA, Vercoulen JHMM, Bazelmans E, Fennis JFM, Bleijenberg G, Van der Meer JWM et al. Viral antibodies in chronic fatigue syndrome. Clin Infect Dis 1995;21:708-9.
93. 93 Swanink CMA, Van der Meer JWM, Vercoulen JHMM, Bleijenberg G, Fennis JFM, Galama JMD. Epstein-Barr virus (EBV) and the chronic fatigue syndrome: normal virus load in blood and normal immunologic reactivity in the EBV regression assay. Clin Infect Dis 1995;20:1390-2.
94. 94 Swanink CMA, Mekhers WJ, Van der Meer JWM, Vercoulen JHMM, Bleijenberg G, Fennis JFM et al. Entero-viruses and the chronic fatigue syndrome. Clin Infect Dis 1994;19:860-4.
95. 95 Vercoulen JHMM, Hommes OR, Swanink CMA, Jongen PJH, Fennis JFM, Galama JMD et al. The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects. Arch Neurol 1996;53:642-9.
96. 96 Vercoulen JHMM, Swanink CMA, Fennis JFM, Galama JMD, Van der Meer JWM, Bleijenberg G. Prognosis in chronic fatigue syndrome: a prospective study on the natural course. J Neurol Neurosurg Psychiatr 1996;60:489-94.
97. 97 Vercoulen JHMM, Swanink CMA, Zitman FG, Vreden SGS, Hoofs MPE, Fennis JFM et al. Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet 1996;347:858-61.
98. 98 Vercoulen JHMM, Swanink CMA, Galama JMD, Fennis JFM, Jongen PJH, Hommes OR et al. The persistence of fatigue in chronic fatigue syndrome and multiple sclerosis: development of a model. J Psychosom Res 1998;45:507-17.
99. 99 Vercoulen JHMM, Bazelmans E, Swanink CMA, Galama JMD, Fennis JFM, Van der Meer JWM et al. Evaluating neuropsychological impairment in chronic fatigue syndrome. J Clin Exp Neuropsychol 1998;20:144-56.
100. 100 Greene S. Push for# Gulf syndrome research. Nature 1993;364:659.
101. 101 Mathews J. Panel urges further research on Gulf war illness, possible increased cancer risks in veterans. J Natl Cancer Inst 1994;86:820-2.
102. 102 Gunby P. Informing troops of investigational drugs, devices. JAMA 1995;273:276.
103. 103 Currie E. The Gulf War syndrome. BMJ 1995;310:1334-5.
104. 104 Roberts J. Gulf war syndrome needs coordinated study. BMJ 1995;310:77.
105. 105 Macilwain C. Call for more coordination of Gulf War syndrome research. Nature 1995;373:92.
106. 106 Gray R. Standardization of health relief items needed in the early phase of emergencies. World Health Stat Q 1996;49:218-20.
107. 107 Graham JT. Investigating Gulf veterans' health concerns. J R Nav Med Serv 1996;82:113-16.